491
Participants
Start Date
November 30, 2009
Primary Completion Date
September 30, 2010
linagliptin low dose
patient to receive tablets containing low dose linagliptin twice daily
placebo
patient to receive placebo tablet(s) matching linagliptin
linagliptin medium dose
patient to receive a tablet containing medium dose linagliptin once daily
1218.62.32003 Boehringer Ingelheim Investigational Site, De Pinte
1218.62.32008 Boehringer Ingelheim Investigational Site, Kortenaken
1218.62.32009 Boehringer Ingelheim Investigational Site, Kumtich
1218.62.32005 Boehringer Ingelheim Investigational Site, Massemen-Wetteren
1218.62.32004 Boehringer Ingelheim Investigational Site, Natoye
1218.62.32007 Boehringer Ingelheim Investigational Site, Sint-Job-in't-Goor
1218.62.32002 Boehringer Ingelheim Investigational Site, Tessenderlo
1218.62.32006 Boehringer Ingelheim Investigational Site, Wilsele
1218.62.11012 Boehringer Ingelheim Investigational Site, Calgary
1218.62.11007 Boehringer Ingelheim Investigational Site, Burnaby
1218.62.11011 Boehringer Ingelheim Investigational Site, St. John's
1218.62.11006 Boehringer Ingelheim Investigational Site, Halifax
1218.62.11001 Boehringer Ingelheim Investigational Site, Barrie
1218.62.11003 Boehringer Ingelheim Investigational Site, Brampton
1218.62.11004 Boehringer Ingelheim Investigational Site, Markham
1218.62.11005 Boehringer Ingelheim Investigational Site, Sarnia
1218.62.11008 Boehringer Ingelheim Investigational Site, Smiths Falls
1218.62.11013 Boehringer Ingelheim Investigational Site, Strathroy
1218.62.11014 Boehringer Ingelheim Investigational Site, Toronto
1218.62.11010 Boehringer Ingelheim Investigational Site, Charlottetown
1218.62.11002 Boehringer Ingelheim Investigational Site, Montreal
1218.62.11009 Boehringer Ingelheim Investigational Site, Point Claire
1218.62.3303C Boehringer Ingelheim Investigational Site, Bort-les-Orgues
1218.62.3306A Boehringer Ingelheim Investigational Site, Bourg Des Cptes
1218.62.3303D Boehringer Ingelheim Investigational Site, Bugeat
1218.62.3302H Boehringer Ingelheim Investigational Site, Corsept
1218.62.3308A Boehringer Ingelheim Investigational Site, Derval
1218.62.3302B Boehringer Ingelheim Investigational Site, La Chapelle-sur-Erdre
1218.62.3304A Boehringer Ingelheim Investigational Site, Levallois-Perret
1218.62.3305A Boehringer Ingelheim Investigational Site, Marseille
1218.62.3305B Boehringer Ingelheim Investigational Site, Marseille
1218.62.3305G Boehringer Ingelheim Investigational Site, Marseille
1218.62.3305H Boehringer Ingelheim Investigational Site, Marseille
1218.62.3301A Boehringer Ingelheim Investigational Site, Nantes
1218.62.3302A Boehringer Ingelheim Investigational Site, Nantes
1218.62.3304B Boehringer Ingelheim Investigational Site, Paris
1218.62.3304D Boehringer Ingelheim Investigational Site, Paris
1218.62.3305F Boehringer Ingelheim Investigational Site, Roquevaire
1218.62.3305I Boehringer Ingelheim Investigational Site, Roquevaire
1218.62.3303A Boehringer Ingelheim Investigational Site, Rosiers-d'Égletons
1218.62.3303H Boehringer Ingelheim Investigational Site, Sainte-Fortunade
1218.62.3302I Boehringer Ingelheim Investigational Site, Sautron
1218.62.3302G Boehringer Ingelheim Investigational Site, Vue
1218.62.91001 Boehringer Ingelheim Investigational Site, Bangalore
1218.62.91004 Boehringer Ingelheim Investigational Site, Bangalore
1218.62.91003 Boehringer Ingelheim Investigational Site, Hyderabad, Andra Pradesh
1218.62.91005 Boehringer Ingelheim Investigational Site, Nagpru
1218.62.91002 Boehringer Ingelheim Investigational Site, Trivandrum
1218.62.39010 Boehringer Ingelheim Investigational Site, Ancona
1218.62.39006 Boehringer Ingelheim Investigational Site, Catania
1218.62.39004 Boehringer Ingelheim Investigational Site, Genova
1218.62.39009 Boehringer Ingelheim Investigational Site, Gissi (CH)
1218.62.39003 Boehringer Ingelheim Investigational Site, Palermo
1218.62.39001 Boehringer Ingelheim Investigational Site, Pisa
1218.62.39002 Boehringer Ingelheim Investigational Site, Pordenone
1218.62.39012 Boehringer Ingelheim Investigational Site, Ravenna
1218.62.39007 Boehringer Ingelheim Investigational Site, Roma
1218.62.39011 Boehringer Ingelheim Investigational Site, Roma
1218.62.60002 Boehringer Ingelheim Investigational Site, George Town
1218.62.60001 Boehringer Ingelheim Investigational Site, Kelantan Kota Bahru
1218.62.60005 Boehringer Ingelheim Investigational Site, Kuala Lumpur
1218.62.60003 Boehringer Ingelheim Investigational Site, Putrajaya
1218.62.60004 Boehringer Ingelheim Investigational Site, Seremban
1218.62.31007 Boehringer Ingelheim Investigational Site, Almere Stad
1218.62.31004 Boehringer Ingelheim Investigational Site, Breezerveld
1218.62.31005 Boehringer Ingelheim Investigational Site, Etten-Leur
1218.62.31002 Boehringer Ingelheim Investigational Site, Lieshout
1218.62.31001 Boehringer Ingelheim Investigational Site, Oude Pekela
1218.62.31008 Boehringer Ingelheim Investigational Site, Voerendaal
1218.62.31009 Boehringer Ingelheim Investigational Site, Wildervank
1218.62.31003 Boehringer Ingelheim Investigational Site, Woerden
1218.62.82005 Boehringer Ingelheim Investigational Site, Goyang
1218.62.82006 Boehringer Ingelheim Investigational Site, Goyang
1218.62.82003 Boehringer Ingelheim Investigational Site, Incheon
1218.62.82004 Boehringer Ingelheim Investigational Site, Pucheon
1218.62.82002 Boehringer Ingelheim Investigational Site, Seoul
1218.62.82001 Boehringer Ingelheim Investigational Site, Suwon
1218.62.34003 Boehringer Ingelheim Investigational Site, Badia Del Vallés (Barcelona)
1218.62.34002 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)
1218.62.34005 Boehringer Ingelheim Investigational Site, Madrid
1218.62.34006 Boehringer Ingelheim Investigational Site, Madrid
1218.62.34007 Boehringer Ingelheim Investigational Site, Madrid
1218.62.34001 Boehringer Ingelheim Investigational Site, Palma (Mallorca)
1218.62.34008 Boehringer Ingelheim Investigational Site, Palma de Mallorca
Lead Sponsor
Boehringer Ingelheim
INDUSTRY